A cost comparison of GLP-1 receptor agonists and bariatric surgery
Discontinued formulations Efpeglenatide and taspoglutide Efpeglenatide and taspoglutide were once-promising, long-acting GLP-1 receptor agonists developed for the treatment of T2DM, both designed for once-weekly administration
Conquering your weight-loss goals with Wegovy, a leading GLP-1 therapy delivered via weekly injections, involves more than just commitment
That could help reduce habits like overeating or smoking by calming brain activity
Find out if replacing regular salt with "lite" salt or salt substitutes, such as Morton Lite Salt, Morton Salt Substitute, NoSalt Original Sodium Free Salt Alternative, and MySalt, helps to reduce blood pressure, or decrease the risk of heart attack and stroke
They represent a paradigm shift: a therapy that goes far beyond symptom management to tackle the root causes of chronic disease